Scotiabank analyst Nick Altmann maintained a Hold rating on Confluent (CFLT – Research Report) today and set a price target of $27.00. The ...

Confluent’s financial performance doesn’t match its premium pricing. Learn why CFLT stock is risky given its minimal ...

JMP Securities maintained a bullish stance on Confluent Inc (NASDAQ:CFLT), reiterating a Market Outperform rating and a ...

JMP Securities analyst Patrick Walravens maintained a Buy rating on Confluent (CFLT – Research Report) today and set a price target of $40.00.

In the last three months, 11 analysts have published ratings on Confluent (NASDAQ:CFLT), offering a diverse range of perspectives from bullish to bearish. The table below offers a condensed view ...

Confluent (NASDAQ:CFLT – Free Report) had its price objective hoisted by Guggenheim from $32.00 to $35.00 in a research note released on Friday morning,Benzinga reports. Guggenheim currently has a buy ...

A large Louisville-based health care firm has made a pair of key C-suite appointments. Confluent Health announced this week ...

Confluent is a terrific "growth at a reasonable price" software stock that has only seen its share price rise ~20% over the past year, despite strong growth. Confluent, founded by creators of open ...

Reported recurrence rates of lentigo maligna treated with Mohs micrographic surgery have ranged from 0.5 to 30.0% in the literature.

DeWanda Wise will star in “Killer Bee,” an adaptation of the upcoming graphic novel from David Crownson that Tommy Oliver ’s ...

Check the time stamp on this data. Updated AI-Generated Signals for Confluent Inc. (CFLT) available here: CFLT. Type a few ...